These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10424518)

  • 1. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
    Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
    Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
    Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
    Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?
    Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G
    J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications.
    Caldarella A; Crocetti E; Comin CE; Janni A; Pegna AL; Paci E
    Cancer; 2006 Aug; 107(4):793-8. PubMed ID: 17024758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes.
    Yano T; Yokoyama H; Inoue T; Asoh H; Tayama K; Ichinose Y
    J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1398-402. PubMed ID: 8196379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.
    Haney JC; Hanna JM; Berry MF; Harpole DH; D'Amico TA; Tong BC; Onaitis MW
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1164-8. PubMed ID: 24507984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
    Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
    Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
    Matsuoka K; Sumitomo S; Misaki N
    J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of main bronchial lymph node involvement in pathological T1-2N1M0 non-small-cell lung cancer: multi-institutional survey by the Japan National Hospital Study Group for Lung Cancer.
    Maeda H; Fukai S; Matsumura A; Kawashima O; Watanabe T; Yamanda T; Okabayashi K; Fujita Y; Tamura A; Kawahara M
    Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):599-604. PubMed ID: 19908114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
    Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    Razi SS; Nguyen D; Villamizar N
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.